Page last updated: 2024-10-23

bisbenzimidazole and Parkinson Disease

bisbenzimidazole has been researched along with Parkinson Disease in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bossolasco, P1
Cova, L1
Levandis, G1
Diana, V1
Cerri, S1
Lambertenghi Deliliers, G1
Polli, E1
Silani, V1
Blandini, F1
Armentero, MT1
Li, J1
Fan, Y1
Zhang, YN1
Sun, DJ1
Fu, SB1
Ma, L1
Jiang, LH1
Cui, C1
Ding, HF1
Yang, J1

Other Studies

2 other studies available for bisbenzimidazole and Parkinson Disease

ArticleYear
Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson's disease.
    International journal of nanomedicine, 2012, Volume: 7

    Topics: Administration, Intranasal; Analysis of Variance; Animals; Bisbenzimidazole; Cell Proliferation; Cel

2012
The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.
    Die Pharmazie, 2012, Volume: 67, Issue:8

    Topics: Apoptosis; Bisbenzimidazole; Blotting, Western; Butadienes; Cell Survival; Enzyme Inhibitors; Flow C

2012